[1] |
MARGULESCU AD, MONT L.Persistent atrial fibrillation vs paroxysmal atrial fibrillation:differences in management[J].Expert Rev Cardiovasc Ther, 2017, 15(8):601. doi: 10.1080/14779072.2017.1355237 |
[2] |
KIRCHHOF P, BENUSSI S, KOTECHA D, et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J].Eur Heart J, 2016, 37(38):2893. doi: 10.1093/eurheartj/ehw210 |
[3] |
ZHENG Y, LIU Y, BI J, et al.Novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation and hypertension:a meta-analysis[J].Am J Cardiovasc Drugs, 2019, 19(5):477. doi: 10.1007/s40256-019-00342-8 |
[4] |
NAZERI A.Clinical challenges of using novel oral anticoagulants for stroke prevention in patients with atrial fibrillation[J].Tex Heart Inst J, 2018, 45(3):164. doi: 10.14503/THIJ-18-6678 |
[5] |
张澍, 孙彤, 程仁立, 等.基层医院非瓣膜病性心房颤动患者抗凝治疗现状及华法林最佳初始剂量研究[J].蚌埠医学院学报, 2011, 36(7):698. |
[6] |
FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR."Mini-mental state".Apractical method for grading the cognitive state of patients for the clinician[J].J Psychiatr Res, 1975, 12(3):189. doi: 10.1016/0022-3956(75)90026-6 |
[7] |
李志武, 黄悦勤, 柳玉芝.中国65岁以上老年人认知功能及影响因素调查[J].第四军医大学学报, 2007, 28(16):1518. |
[8] |
曾毅.健康长寿影响因素分析[M].北京:北京大学出版社, 2004:3. |
[9] |
ECKARDT L, HÄUSLER KG, RAVENS U, et al.ESC guidelines on atrial fibrillation 2016:Summary of the most relevant recommendations and modifications[J].Herz, 2016, 41(8):677. doi: 10.1007/s00059-016-4503-8 |
[10] |
ANDRADE AA, LI J, RADFORD MJ, et al.Clinical benefit of American college of chest physicians versus European society of cardiology guidelines for stroke prophylaxis in atrial fibrillation[J].J Gen Intern Med, 2015, 30(6):777. doi: 10.1007/s11606-015-3201-1 |
[11] |
HOSPODAR AR, SMITH KJ, ZHANG Y, et al.Comparing the cost effectiveness of non-vitamin K antagonist oral anticoagulants with well-managed warfarin for stroke prevention in atrial fibrillation patients at high risk of bleeding[J].Am J Cardiovasc Drugs, 2018, 18(4):317. doi: 10.1007/s40256-018-0279-y |
[12] |
XIAN Y, O'BRIEN EC, LIANG L, et al.Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation[J].JAMA, 2017, 317(10):1057. doi: 10.1001/jama.2017.1371 |
[13] |
ROCKET AF.Study Investigators.Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation:rationale and design of the ROCKET AF study[J].Am Heart J, 2010, 159(3):340. doi: 10.1016/j.ahj.2009.11.025 |
[14] |
CASADO NARANJO Ⅰ, PORTILLA CUENCA JC, DUQUE DE SAN JUAN B, et al.Association of vascular factors and amnestic mild cognitive impairment:a comprehensive approach[J].J Alzheimers Dis, 2015, 44(2):695. |
[15] |
ALDRUGH S, SARDANA M, HENNINGER N, et al.Atrial fibrillation, cognition and dementia:a review[J].J Cardiovasc Electrophysiol, 2017, 29(8):958. |
[16] |
GALENKO O, JACOBS Ⅴ, KNIGHT S, et al.Circulating levels of biomarkers of cerebral injury in patients with atrial fibrillation[J].Am J Cardiol, 2019, 124(11):1697. doi: 10.1016/j.amjcard.2019.08.027 |
[17] |
WU Y, CHEN T.An up-to-date review on cerebral microbleeds[J].J Stroke Cerebrovasc Dis, 2016, 25(6):1301. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.005 |
[18] |
CHOU RH, CHIU CC, HUANG CC, et al.Prediction of vascular dementia and Alzheimer's disease in patients with atrial fibrillation or atrial flutter using CHADS 2 score[J].Chin Med Assoc, 2016, 79(9):470. doi: 10.1016/j.jcma.2016.02.007 |
[19] |
VISCOGLIOSI G, ETTORRE E, CHIRIAC IM.Dementia correlates with anticoagulation underuse in older patients with atrial fibrillation[J].Arch Gerontol Geriatr, 2018, 72:108. |
[20] |
MAVADDAT N, ROALFE A, FLETCHER K, et al.Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)[J].Stroke, 2014, 45(5):1381. doi: 10.1161/STROKEAHA.113.004009 |
[21] |
FERLAND G, FEART C, PRESSE N, et al.Vitamin K antagonists and cognitive function in older adults:the three-city cohort study[J].J Gerontol A Biol Sci Med Sci, 2016, 71(10):1356. doi: 10.1093/gerona/glv208 |